← Back to catalogue

AxSYM Core 2.0 (LN 8B88)

FDA PMA

Class II (US FDA PMA)

PMA P060012

by Abbott Laboratories, Inc.

Identity

Trade Name
AXSYM CORE 2.0 AND AXSYM CORE 2.0 CONTROLS FDA PMA
Generic Name
Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen) FDA PMA

Identifiers

PMA Number
P060012 FDA PMA
FDA Product Code
LOM FDA PMA

Classification

Device Class
Class II FDA PMA
Legislation / Framework
21 CFR Part 866.3172 FDA PMA
Regulation Number
866.3172 FDA PMA
Advisory Committee
Microbiology FDA PMA
FDA Decision
APWD FDA PMA

The AxSYM Core 2.0 is a microparticle enzyme immunoassay (MEIA) device designed for the qualitative detection of total antibodies (IgG and IgM) to hepatitis B virus core antigen (anti-HBC) in serum or plasma. It aids in diagnosing acute, chronic, or resolved hepatitis B virus (HBV) infection when used alongside other laboratory results and clinical information.

The AxSYM Core 2.0 is intended for use in clinical microbiology laboratories and requires the AxSYM system for operation. It is supplied as a single-use reagent kit, with controls provided for monitoring system performance. The device is FDA-authorized under PMA (P060012) and classified under product code LOM, adhering to regulatory standards for microbiological testing.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: PDF AxSYM CORE - Food and Drug Administration, AXSYM CORE 2.0 AND AXSYM CORE 2.0 CONTROLS (P060012) — FDA 510 (k ..., AXSYM CORE 2.0 AND AXSYM CORE 2.0 CONTROLS - fda.report, PDF Summary of Safety and Effectiveness Data

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_PMA

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA PMA P060012 24 fields · synced Sep 18, 2026